Inflammation and limited adaptive immunity predict worse outcomes on immunotherapy in head and neck cancer

  • Chow, L. Q. M. Head and neck cancer. N. Engl. J. Med. 382, 60–72 (2020).

    Google Scholar 

  • Johnson, D. E. et al. Head and neck squamous cell carcinoma. Nat. Rev. Dis. Primers 6, 92 (2020).

  • Continue Reading